1st Quarter - Report
THE MCMANUS GROUP for GENENTECH
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to comparative effectiveness. S. 2029, "Physician Payments Sunshine Act of 2007," all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Pharmacy PHA
H.R. 1038, "Access to Life-Savings Medicine Act," all provisions. H.R. 5629, "Pathway for Biosimilars Act," all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.